Critical Analysis: Henry Schein (NASDAQ:HSIC) vs. RHÖN-KLINIKUM Aktiengesellschaft (OTCMKTS:RKAGY)

Henry Schein (NASDAQ:HSIC) and RHÖN-KLINIKUM Aktiengesellschaft (OTCMKTS:RKAGY) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability and valuation.

Analyst Ratings

This is a summary of recent ratings and price targets for Henry Schein and RHÖN-KLINIKUM Aktiengesellschaft, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1	5	9	0	2.53
RHÖN-KLINIKUM Aktiengesellschaft	0	0	0	0	0.00

Henry Schein currently has a consensus target price of $92.93, suggesting a potential upside of 5.01%. Given Henry Schein’s stronger consensus rating and higher possible upside, research analysts clearly believe Henry Schein is more favorable than RHÖN-KLINIKUM Aktiengesellschaft.

Earnings and Valuation

This table compares Henry Schein and RHÖN-KLINIKUM Aktiengesellschaft”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18 billion	0.75	$398.00 million	$3.43	25.80
RHÖN-KLINIKUM Aktiengesellschaft	N/A	N/A	N/A	$4.50	1.81

Henry Schein has higher revenue and earnings than RHÖN-KLINIKUM Aktiengesellschaft. RHÖN-KLINIKUM Aktiengesellschaft is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

96.6% of Henry Schein shares are held by institutional investors. Comparatively, 0.2% of RHÖN-KLINIKUM Aktiengesellschaft shares are held by institutional investors. 0.9% of Henry Schein shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Henry Schein and RHÖN-KLINIKUM Aktiengesellschaft’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.96%	15.97%	5.56%
RHÖN-KLINIKUM Aktiengesellschaft	N/A	N/A	N/A

Summary

Henry Schein beats RHÖN-KLINIKUM Aktiengesellschaft on 10 of the 11 factors compared between the two stocks.

About Henry Schein

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

About RHÖN-KLINIKUM Aktiengesellschaft

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. It also operates acute hospitals, medical care centers, and rehabilitation hospitals. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.